Found 6 matching trials
Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia NA The aim of this study is to determine the safety and therapeutic effect of ...
Show More Location
Riphah International University
Learn More & Join Trial
Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients PHASE3 The goal of this Non-Randomized Clinical Trial is to determine the effects ...
Show More Location
Blood Care Clinic
Learn More & Join Trial
Long Term Beta Thalassemia Treatment: Findings From The Extension Period PHASE2 The project, titled "Long Term Beta Thalassemia Treatment: Findings From Th...
Show More Status
Active Not Recruiting
Location
National Institute of blood disease and bone marrow transplant
Learn More & Join Trial
Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia PHASE2 Thalidomide is known to have hypnosedative, immuno-modulatory and anti-angi...
Show More Location
Blood Diseases Clinic
Learn More & Join Trial
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment PHASE3 The purpose of the study is to evaluate the overall survival of participant...
Show More Status
Active Not Recruiting
Location
University of California-San Diego/Moores UCSD Cancer Center
Learn More & Join Trial
Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia PHASE2 Beta thalassemia Major (BTM) is the most common hemoglobinopathy caused by ...
Show More Location
Armed Forces Bone Marrow Transplant Center
Learn More & Join Trial